Peregrine Capital Management LLC ARRAY BIOPHARMA Transaction History

Peregrine Capital Management LLC

  • $3.18 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 16, 2019
SELL
N/A
-544,364 Closed
0 $0
Q2 2019

Jul 18, 2019
SELL
N/A
-417,284 Reduced 43.39%
544,364 $0
Q1 2019

Apr 12, 2019
SELL
N/A
-150,000 Reduced 13.49%
961,648 $0
Q4 2018

Jan 17, 2019
SELL
N/A
-6,756 Reduced 0.6%
1,111,648 $0
Q3 2018

Oct 18, 2018
BUY
N/A
1,118,404 New
1,118,404 $0
Track This Portfolio

Track Peregrine Capital Management LLC Portfolio

Follow Peregrine Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email